QGEN earnings date and last-quarter result: last quarter beat, P/E 21.47. Updated 2026-07-23.
Qiagen (QGEN) Research Hub
Qiagen (QGEN) trades on NYSE, NL in the Healthcare (Medical - Diagnostics & Research) sector. As of 2026-10-26, shares last closed at 50.37 USD (-0.04%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 21.47, market cap 8.35B. This hub links to the full technical, earnings and options research available for QGEN.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Diagnostics & Research) |
|---|---|
| Exchange | NYSE, NL |
| Last close | 50.37 USD (-0.04%) |
| 52-week range | 36.28 USD – 50.82 USD |
| Trend regime | Range |
| 14-day RSI | 82.7 (Overbought) |
| Trailing P/E | 21.47 |
| Market cap | 8.35B |
| Dividend yield | 6.51% |
Available research for QGEN
Covered Call on QGEN: how it works, illustrative setup around the real 50.37 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on QGEN: how it works, illustrative setup around the real 50.37 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on QGEN: how it works, illustrative setup around the real 50.37 USD price, max profit/loss, breakeven and when to use it. Educational.
QGEN technical analysis: range, last 50.37 USD, RSI 82.7, 52w range 36.28 USD–50.82 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is QGEN in?
Qiagen (QGEN) is classified under Healthcare (Medical - Diagnostics & Research), listed on NYSE, NL.
Is QGEN in an uptrend or downtrend?
As of 2026-10-26, QGEN is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is QGEN's trailing P/E ratio?
QGEN's trailing P/E is 21.47, with a market cap of 8.35B. See the earnings research page for full valuation detail.